SPECTACLES
Received May 19, 2020 · Event occurred Jan 1, 2020
Report MW5094612 · MDR key 10075699
Device
Generic name
Lens, Spectacle, Non-custom (prescription)
Manufacturer
UnkProduct problems
- Product Quality Problem
Patient
75 YR
- No Known Impact Or Consequence To Patient
- No Known Impact Or Consequence To Patient
Narrative
Description of Event or Problem
SPECTACLE (21 CFR SECTION 886.5844) SELLER BUNDLED "COATING" WITH SALE OF PRESCRIPTION EYEGLASSES. THE COATING HAS WORN UNEVENLY, AND CANNOT BE CLEANED. MERCHANT SAYS (AND WEB ARTICLES STATE) THAT THE "COATING" CANNOT BE REMOVED, SO I AM STUCK WITH GLASSES OF THE RIGHT PRESCRIPTION, BUT BLOTCHY "COATING". WHERE MAY I SEE FDA'S APPROVAL OR CLEARANCE OF SUCH COATINGS? HOW LONG DID THE MANUFACTURER OF EYEGLASS COATING SUBSTANCES TELL FDA THEY WOULD LAST? DOES FDA CLAIM THAT BLOTCHY COATINGS ARE, OR ARE NOT SIGNIFICANT TO THE USER? WHERE MAY I REVIEW THE NUMBER OF SIMILAR COMPLAINTS TO FDA ABOUT EYEGLASS COATINGS? I HAVE NO TESTS. I DO NOT BELIEVE THAT I HAVE BEEN INJURED BY THIS DEVICE, BUT I BELIEVE THE CHARACTERISTIC OF UNEVEN WEAR OF SUCH COATINGS IS A QUALITY ISSUE THAT SHOULD BE THE SUBJECT OF REQUIRED FDA-DIRECTED WARNING LABELS ON ALL SUCH PRODUCTS, AND THAT FDA SHOULD PUBLISH AN ALERT TO EYEGLASS CUSTOMERS ABOUT THE FACT AND LIKELIHOOD OF SUCH DEGRADATION FOR COATED EYEGLASSES, BOUGHT AT (B)(6); NEEDS GLASSES. NEEDS EFFECTIVE GOVERNMENT REGULATION AND ENFORCEMENT FOR DEVICES. FDA SAFETY REPORT ID# (B)(4).